Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Kumar, Runjun D ^a,b   Chang, Li Wei ^a   Ellis, Matthew J ^a,c   Bose, Ron ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN KINASE; ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RESEARCH; DRUGGABLE GENES; GENE CONSTRUCT; GENE SEQUENCE; GENETIC DATABASE; GENETIC IDENTIFICATION; HUMAN; LUNG SQUAMOUS CELL CARCINOMA; MUTATIONAL ANALYSIS; SOMATIC MUTATION; BIOLOGY; GENETICS; HUMAN GENOME; MOLECULAR GENETICS; MUTATION; NEOPLASM; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTINEOPLASTIC AGENTS; COMPUTATIONAL BIOLOGY; GENOME, HUMAN; HUMANS; MOLECULAR SEQUENCE ANNOTATION; MUTATION; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84879508865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067980     Document Type: Article

References (25)

1. The Cancer Genome Atlas Research Network, (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489: 519-525.
2. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, et al. (2012) Whole Genome Sequencing to Characterise Breast Cancer Response to Aromatase Inhibition. Nature 486: 353-360.
3. Hopkins AL & Groom CR, (2002) The druggable genome. Nat Rev Drug Discov 1: 727-730.
4. Russ AP & Lampel S, (2005) The druggable genome: an update. Drug Discov Today 10: 1607-1610.
5. Somaiah N & Simon GR, (2011) Molecular targeted agents and biologic therapies for lung cancer. J Thorac Oncol 6: S1758-1785.
6. Vroling B, Thorne D, McDermott P, Joosten H, Attwood TK, et al. (2012) NucleaRDB: information system for nuclear receptors. Nucleic Acids Res 40: D377-380.
7. Rawlings ND, Barrett AJ & Bateman A, (2012) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 40: D343-350.
8. Vroling B, Sanders M, Baakman C, Borrmann A, Verhoeven S, et al. (2011) GPCRDB: Information system for G protein-coupled receptors. Nucleic Acids Res 39: D309-D319.
9. Apweiler R, Martin MJ, O'Donovan C, Magrane M, Alam-Faruque Y, et al. (2012) Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40: D71-D75.
10. Blake JA, Dolan M, Hill DP, Ni L, Sitnikov D, et al. (2012) The Gene Ontology: Enchancements for 2011. Nucleic Acids Res 40: D559-D564.
11. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S, (2002) The protein kinase complement of the human genome. Science 298: 1912-1934.
12. Tonks NK. 2006. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7: 833-846.
13. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, et al. (2004) Protein tyrosine phosphatases in the human genome. Cell 117: 699-711.
14. Engelman JA, Luo J, (2006) Cantley LC, (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619.
15. Huang CH, Mandelker D, Schmidt-Kittler O, Samuels Y, Velculescu VE, et al. (2007) The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science 318: 1744-1748.
16. Condomines M, Hose D, Reme T, Requirand G, Hundemer M, et al. (2009) Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma. J Immunol 183: 832-840.
17. Kelemen LE, Wang X, Fredericksen ZS, Pankrats VS, Pharoah PDP, et al. (2009) Genetic variation in the chromosome 17q23 amplicon and breast cancer risk. Cancer Epidemiol Biomarkers Prev 18: 1864-1868.
18. Pejovic T, Pande NT, Mori M, Mhawech-Fauceglia P, Harrington C, et al. (2009) Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. Transl Oncol 2: 341-349.
19. Weber A, Huesken C, Bergmann E, Kiess W, Christiansen NM, et al. (2003) Coexpression of insulin receptor-related receptor and insulin-like growth factor 1 receptor correlates with enhanced apoptosis and dedifferentiation in human neuroblastomas. Clin Cancer Res 9: 5683-5692.
20. Mishra RR, Chaudhary JK, Bajaj GD & Rath PC, (2011) A novel human TPIP splice-variant (TPIP-C2) mRNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells. PLoS ONE 6: e28433.
21. Mishra RR, Chaudhary JK & Rath PC, (2012) Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells. Mol Biol Rep 39: 7389-7402.
22. Walker SM, Downes CP & Leslie NR, (2001) TPIP: a novel phosphoinositide 3-phosphatase. Biochem J 360: 277-283.
23. Ng PC, Henikoff S, (2001) Predicting Deleterious Amino Acid Substitutions. Genome Res. 11 (5): 863-874.
24. Reva B, Antipin Y, Sander C. (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. doi:10.1093/nar/gkr407.
25. Huang DW, Sherman BT, Stephens R, Baseler MW, Lane HC, et al. (2008) DAVID gene ID conversion tool. Bioinformation 2: 428-430.